Cargando…

STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer

Mechanisms of castration-resistant prostate cancer (CRPC) are not well understood, thus hindering rational-based drug design. Activation of STAT3/5A, key components of the JAK/STAT pathway, is implicated in aggressive PC, yet their clinical relevance in CRPC remains elusive. Here, we evaluated the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohanty, Sambit K., Yagiz, Kader, Pradhan, Dinesh, Luthringer, Daniel J., Amin, Mahul B., Alkan, Serhan, Cinar, Bekir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689662/ https://www.ncbi.nlm.nih.gov/pubmed/29156772 http://dx.doi.org/10.18632/oncotarget.20844

Ejemplares similares

Mapping the STK4/Hippo signaling network in prostate cancer cell
por: Ready, Damien, et al.
Publicado: (2017)

Hypoxic Tumor Kinase Signaling Mediated by STAT5A in Development of Castration-Resistant Prostate Cancer
por: Røe, Kathrine, et al.
Publicado: (2013)

MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
por: Gan, Junqing, et al.
Publicado: (2022)

The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer
por: Lo, U‐Ging, et al.
Publicado: (2022)

Enzalutamide-Resistant Progression of Castration-Resistant Prostate Cancer Is Driven via the JAK2/STAT1-Dependent Pathway
por: Luo, Yong, et al.
Publicado: (2021)

The ARAMIS trial: Why Darolutamide is better than apalutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer
por: Tripathy, Sambit
Publicado: (2021)

Targeting STAT3 and STAT5 in Cancer
por: de Araujo, Elvin D., et al.
Publicado: (2020)

STAT3 and STAT5 Activation in Solid Cancers
por: Igelmann, Sebastian, et al.
Publicado: (2019)

New Therapeutics to Treat Castrate-Resistant Prostate Cancer
por: Acar, Ömer, et al.
Publicado: (2013)

Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
por: Wu, Chin-Jui, et al.
Publicado: (2019)

Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer
por: Erb, Holger H. H., et al.
Publicado: (2020)

Direct Targeting Options for STAT3 and STAT5 in Cancer
por: Orlova, Anna, et al.
Publicado: (2019)

Companion Animals as Models for Inhibition of STAT3 and STAT5
por: Kieslinger, Matthias, et al.
Publicado: (2019)

BCR-ABL Affects STAT5A and STAT5B Differentially
por: Schaller-Schönitz, Michael, et al.
Publicado: (2014)

Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
por: Bumbaca, Brandon, et al.
Publicado: (2018)

Phosphorylated Forms of STAT1, STAT3 and STAT5 Are Expressed in Proliferating but Not Involuted Infantile Hemangioma
por: Sulzberger, Lucy, et al.
Publicado: (2018)

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer()
por: Heidegger, Isabel, et al.
Publicado: (2013)

Identification of STAT5A and STAT5B Target Genes in Human T Cells
por: Kanai, Takahiro, et al.
Publicado: (2014)

Differential cytokine sensitivities of STAT5-dependent enhancers rely on Stat5 autoregulation
por: Willi, Michaela, et al.
Publicado: (2016)

STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity
por: Able, Ashley A., et al.
Publicado: (2017)

STAT5A and STAT5B—Twins with Different Personalities in Hematopoiesis and Leukemia
por: Maurer, Barbara, et al.
Publicado: (2019)

Multiplexed Quantum Dot Labeling of Activated c-Met Signaling in Castration-Resistant Human Prostate Cancer
por: Hu, Peizhen, et al.
Publicado: (2011)

Expression of tSTAT3, pSTAT3(727), and pSTAT3 (705) in the epithelial cells of hormone‐naïve prostate cancer
por: Krzyzanowska, Agnieszka, et al.
Publicado: (2019)

Escorting STAT5A
por: LeBrasseur, Nicole
Publicado: (2004)

Involvement of STAT5 in Oncogenesis
por: Halim, Clarissa Esmeralda, et al.
Publicado: (2020)

Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer
por: Asangani, Irfan A., et al.
Publicado: (2014)

Novel non-AR therapeutic targets in castrate resistant prostate cancer
por: Toren, Paul J., et al.
Publicado: (2013)

What is the next generation therapeutic strategy for castration-resistant prostate cancer
por: Wen, Si-Meng, et al.
Publicado: (2015)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
por: Naseer, Faiza, et al.
Publicado: (2021)

The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia
por: Shi, Aiping, et al.
Publicado: (2015)

The Expression of STAT3 and STAT5A Genes in Severe Refractory Asthma
por: Saeedfar, Kayvan, et al.
Publicado: (2017)

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
por: Brachet-Botineau, Marie, et al.
Publicado: (2020)

STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases
por: Logotheti, Stella, et al.
Publicado: (2019)

Structural Implications of STAT3 and STAT5 SH2 Domain Mutations
por: de Araujo, Elvin D., et al.
Publicado: (2019)

Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
por: Gleixner, Karoline V., et al.
Publicado: (2017)

STAT5b in LGL leukemia – a novel therapeutic target?
por: Rajala, Hanna L. M., et al.
Publicado: (2013)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a**
por: Elumalai, Nagarajan, et al.
Publicado: (2015)

Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy
por: Verdeil, Grégory, et al.
Publicado: (2019)

Selective activation of STAT3 and STAT5 dictates the fate of myeloid progenitor cells
por: Zhang, Meichao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t0gih35j8denn61ebun76v84av